Common use of Agent’s Review of Proposed Amendments and Supplements Clause in Contracts

Agent’s Review of Proposed Amendments and Supplements. Prior to amending or supplementing the Registration Statement (including any registration statement filed under Rule 462(b) under the Securities Act) or the Prospectus (including any amendment or supplement through incorporation by reference of any report filed under the Exchange Act), the Company shall use commercially reasonable efforts to furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, and the Company shall use commercially reasonable efforts to not file or use any such proposed amendment or supplement without first consulting with the Agent, and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.

Appears in 2 contracts

Samples: Open Market Sale Agreement (General Maritime Corp / MI), Open Market Sale Agreement (General Maritime Corp / MI)

AutoNDA by SimpleDocs

Agent’s Review of Proposed Amendments and Supplements. Prior During any period in which an Issuance Notice is pending, prior to amending or supplementing the Registration Statement (including any registration statement filed under Rule 462(b) under the Securities ActRegistration Statement) or the Prospectus (including excluding any amendment or supplement through incorporation by reference of any report filed under the Exchange Act), the Company shall use commercially reasonable efforts to furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, and the Company shall use commercially reasonable efforts to not file or use any such proposed amendment or supplement without first consulting with the Agent’s prior consent (not to be unreasonably withheld), and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.

Appears in 2 contracts

Samples: Capital on Demand Sales Agreement (Aeglea BioTherapeutics, Inc.), Capital on Demand Sales Agreement (Aeglea BioTherapeutics, Inc.)

Agent’s Review of Proposed Amendments and Supplements. Prior to amending or supplementing the Registration Statement (including any registration statement filed under Rule 462(b) under the Securities ActRegistration Statement) or the Prospectus (including excluding any amendment or supplement through incorporation by reference of any report filed under the Exchange Act), the Company shall use commercially reasonable efforts to furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, and and, if such proposed amendment or supplement relates to the matters contemplated by this Agreement, the Company shall use commercially reasonable efforts to not file or use any such proposed amendment or supplement without first consulting with the Agent’s prior consent, and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.

Appears in 1 contract

Samples: Open Market Sale Agreement (HOOKIPA Pharma Inc.)

Agent’s Review of Proposed Amendments and Supplements. Prior to amending or supplementing the Registration Statement (including Statement, any registration statement filed under Rule 462(b) under the Securities Act) Registration Statement or the Prospectus (including excluding any amendment or supplement through incorporation by reference of any report filed under the Exchange Act), the Company shall use commercially reasonable efforts to furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, insofar as such proposed amendment or supplement relates to the transactions contemplated hereby, and the Company shall use commercially reasonable efforts to not file or use any such proposed amendment or supplement without first consulting with the Agent’s prior consent, and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.

Appears in 1 contract

Samples: Open Market Sale Agreement (Ayala Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Agent’s Review of Proposed Amendments and Supplements. Prior to amending or supplementing the Registration Statement (including any registration statement filed under Rule 462(b) under the Securities ActRegistration Statement) or the Prospectus (including any amendment or supplement through incorporation by reference of any report filed under the Exchange Act)Act in connection with this Agreement and the Shares) relating to the Shares, the Company shall use commercially reasonable efforts to furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, and the Company shall use commercially reasonable efforts to not file or use any such proposed amendment or supplement without first consulting with the Agent’s prior written consent, such consent not to be unreasonably withheld or delayed, and to the Company shall file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.

Appears in 1 contract

Samples: Open Market Sale Agreement (Sangamo Therapeutics, Inc)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!